SCHEMBL4986346

SCHEMBL4986346

CCOC(=O)CN[C@H](CCOC(C)=O)C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 2/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
TSHR P16473 1/20 0.39
ALOX15 P16050 1/20 0.35
CAD P27708 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
TRPA1 O75762 1/20 0.33
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3031703 1.00 L3MBTL1 (0.44) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL21271462 0.81 L3MBTL1 (0.65) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL21271459 0.81 L3MBTL1 (0.65) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL21271460 0.81 L3MBTL1 (0.65) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL11186485 0.79 GAA (0.48) L3MBTL1KMT2APOLBALDH1A1GAA
SCHEMBL5330001 0.79 L3MBTL1 (0.53) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL5409583 0.74 L3MBTL1 (0.51) L3MBTL1KMT2APOLBALDH1A1HSD17B10
1,6-Hexanediol SCHEMBL28962667 0.73 KMT2A (0.43) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL7314127 0.71 GAA (0.52) L3MBTL1KMT2APOLBALDH1A1HSD17B10
SCHEMBL13559155 0.71 ALDH1A1 (0.54) L3MBTL1KMT2APOLBALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651237-A4 METHODS FOR TREATMENT OF DERMATOLOGICAL CONDITIONS JOHNSON & JOHNSON CONSUMER (US) 2008-10-01 EP disclosed
EP-1651237-A2 METHODS FOR TREATMENT OF DERMATOLOGICAL CONDITIONS Galileo Pharmaceuticals, Inc. (US) 2006-05-03 EP disclosed
WO-2005016270-A2 METHODS FOR TREATMENT OF DERMATOLOGICAL CONDITIONS GALILEO PHARMACEUTICALS, INC. (US) 2005-02-24 WO disclosed